HF Information
Medical History & Labs
Current HF Therapies
Endpoint: | The MAGGIC risk score only estimates mortality at 1 and 3 years |
Time period: | year(s) |
Note for EMR |
Risk of dying within 1 year:
Current
With Therapy
No Event | Treatment Benefit | Event |
Possible Side Effects
Displayed percentages represent the absolute risk increase compared to placebo (except for sacubitril-valsartan, which was compared to ACE inhibitor). Only differences found to be statistically significant in randomized controlled trials are shown.
Other Treatment Information
HFMedChoice is a decision support tool intended for use by healthcare professionals. It is not meant to be a substitute for professional advice.
Version 2020.1 - © 2020 Ricky Turgeon